Atara Biotherapeutics Inc.
ATRA | NASDAQ
$8.01
-$0.52 (-6.10%)
At close: Oct 30, 2026, 4:00 PM ET
$8.01
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:54 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -16.69M | -9.47M | 32.69M | 23.4M | 5.8M | -15.64M | -85.4M | -133.16M | -181.05M | -233.11M | -276.13M | -290.25M | -304.54M | -214.97M | -228.3M | -247.08M | -247.65M | -349.91M | -340.14M | -328.1M | -317.78M | -311.45M |
Depreciation & Amortization | 99K | 350K | 2.12M | 3.17M | 4.36M | 5.46M | 5.05M | 5.16M | 5.14M | 5.01M | 4.83M | 4.88M | 5.04M | 5.28M | 5.65M | 6.89M | 7.83M | 8.71M | 9.35M | 9.01M | 8.87M | 8.61M |
Stock-Based Compensation | 3.89M | 6.29M | 9.75M | 14.08M | 19.28M | 22.81M | 27M | 31.08M | 35.8M | 42.02M | 45.39M | 46.82M | 49.7M | 51.27M | 53.84M | 56.5M | 56.24M | 55.93M | 53.87M | 51.34M | 50.83M | 50.98M |
Other Working Capital | -9.11M | -31.5M | -111.38M | -133.26M | -124.46M | -139.43M | -59.84M | -2.92M | -8.84M | 32.31M | 20.48M | 34.44M | 38.24M | -18.44M | -13.02M | -17.62M | -15.01M | 37.84M | 43.25M | 62.13M | 62.89M | 68.66M |
Other Non-Cash Items | 712K | 326K | 9.24M | 14.8M | 17.38M | 21.47M | 15.59M | 18.1M | 18.52M | 17.87M | 17.59M | 14.34M | 13.15M | -37.47M | -40.15M | -41.86M | -43.85M | 4.2M | 3.83M | 3.37M | 3.11M | 2.82M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -9.9M | -23.38M | -104.74M | -125.17M | -110.73M | -101.34M | -30.96M | -15.83M | -20.42M | -15.94M | 15.34M | 24.75M | 23.49M | -28.43M | -61.47M | -22.27M | -14.32M | 41.71M | 52.58M | 74M | 70.62M | 69.63M |
Operating Cash Flow | -21.9M | -25.88M | -50.94M | -69.71M | -63.92M | -67.24M | -68.72M | -94.65M | -142.01M | -184.16M | -192.98M | -199.45M | -213.16M | -224.33M | -270.43M | -247.82M | -241.74M | -239.35M | -220.52M | -190.37M | -184.35M | -179.41M |
Capital Expenditures | n/a | n/a | n/a | -90K | -90K | -119K | -246K | -200K | -481K | -951K | -1.22M | -1.22M | -1.07M | -1.99M | -4.19M | -6.62M | -10.35M | -10.99M | -10.58M | -8.72M | -5.36M | -5.38M |
Cash Acquisitions | 44K | 44K | 44K | 44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -9.09M | -2.47M | -2.47M | -2.47M | -19.67M | -19.67M | -19.67M | -19.67M | -1K | -15.75M | -83.65M | -83.07M | -99.15M | -222.07M | -180.59M | -257.54M | -307.35M | -233.5M | -301.13M | -371.43M | -356.51M | -463.07M |
Sales Maturities Of Investments | 7.89M | 7.89M | 25.09M | 20.67M | 23.67M | 30.89M | 28.54M | 35.06M | 102.76M | 161.26M | 208.71M | 249.4M | 254.6M | 266.02M | 292.97M | 296.81M | 291.84M | 313.46M | 333.97M | 389.84M | 377.93M | 322.25M |
Other Investing Acitivies | 555K | -4.86M | -4.86M | -5.42M | -5.42M | n/a | n/a | n/a | 25K | 25K | 25K | 25K | n/a | 94.77M | 94.77M | 94.77M | 94.77M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -607K | 949K | 18.15M | 13.08M | -1.16M | 11.11M | 8.62M | 15.19M | 102.3M | 144.59M | 123.87M | 165.14M | 154.39M | 136.73M | 202.96M | 127.41M | 68.91M | 68.97M | 22.26M | 9.69M | 16.06M | -146.2M |
Debt Repayment | n/a | n/a | -250K | -485K | -682K | -915K | -892K | -872K | -883K | -862K | -947K | -854K | -852K | -766K | -518K | -458K | -314K | -252K | -254K | -292K | -322K | -365K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1K | -1K | -1K | 129K | -14.71M | 229K | 223K | 287K | 15.11M | 908K | 821K | 1.07M | 1.06M | 1.64M | 1.11M | 2.25M | 3.1M | 4.38M | 5.5M | 7.2M | 6.41M | 5.73M |
Financial Cash Flow | 8.82M | 19.3M | 16.1M | 15.77M | 50.52M | 34.89M | 59.28M | 61.12M | 25.12M | 25.92M | 2.01M | 32.79M | 32.78M | 33.47M | 53.08M | 72.26M | 119.61M | 120.9M | 103.94M | 231.27M | 217.64M | 406.51M |
Net Cash Flow | -13.68M | -5.63M | -16.69M | -40.86M | -14.56M | -21.25M | -811K | -18.34M | -14.58M | -13.65M | -67.1M | -1.52M | -25.99M | -54.13M | -14.39M | -48.14M | -53.22M | -49.48M | -94.32M | 50.59M | 49.35M | 80.89M |
Free Cash Flow | -21.9M | -25.88M | -50.94M | -69.8M | -64.01M | -67.36M | -68.96M | -94.85M | -142.49M | -185.11M | -194.2M | -200.67M | -214.23M | -226.32M | -274.62M | -254.44M | -252.09M | -250.34M | -231.1M | -199.09M | -189.72M | -184.79M |
Adj. Free Cash Flow | -25.78M | -32.17M | -60.69M | -83.89M | -83.28M | -90.18M | -95.96M | -125.93M | -178.29M | -227.13M | -239.59M | -247.49M | -263.93M | -277.58M | -328.46M | -310.94M | -308.33M | -306.27M | -284.97M | -250.43M | -240.55M | -235.77M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -281K | -780K | -1.18M | -1.22M | -1.07M | -568K | -169K | -132K | n/a | n/a | n/a | -601K | -1.1M | -3.16M |
Growth CapEx | n/a | n/a | n/a | -90K | -90K | -119K | -246K | -200K | -200K | -171K | -44K | n/a | n/a | -1.42M | -4.02M | -6.49M | -10.35M | -10.99M | -10.58M | -8.11M | -4.26M | -2.22M |
Owner Earnings | -21.9M | -25.88M | -50.94M | -69.71M | -63.92M | -67.24M | -68.72M | -94.65M | -142.29M | -184.94M | -194.16M | -200.67M | -214.23M | -224.9M | -270.6M | -247.95M | -241.74M | -239.35M | -220.52M | -190.97M | -185.46M | -182.57M |
Add to Watchlist
Select watchlists to add or remove ATRA